Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

BACKGROUND AND AIMS: Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve the new LDL-C goals recommended in the 2019 ESC/EAS guidelines (<70 and < 55 mg/dL, respectively). To what extent pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrières, Jean, Hildebrandt, Per, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L.J., Catapano, Alberico L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833224/
https://www.ncbi.nlm.nih.gov/pubmed/36644508
http://dx.doi.org/10.1016/j.athplu.2021.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833224/
https://www.ncbi.nlm.nih.gov/pubmed/36644508
http://dx.doi.org/10.1016/j.athplu.2021.08.003

Ejemplares similares